LexDanaLexDanabeta
Inventor

Dean Boyall

Inventor
Faringdon, GB

Overview

27→
Patents
2009–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
A01KAnimal husbandry2%
PatentTitleYear
11,117,900Compounds useful as inhibitors of ATR kinase202110,787,452Compounds useful as inhibitors of ATR kinase202010,392,391Compounds useful as inhibitors of ATR kinase20199,718,827'Compounds useful as inhibitors of ATR kinase'20179,650,381'Compounds useful as inhibitors of ATR kinase'20179,499,497'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'20169,340,546'Compounds useful as inhibitors of ATR kinase'20169,193,722'Tri-cyclic pyrazolopyridine kinase inhibitors'20159,137,973'Pyrazolopyridine kinase inhibitors'20159,073,875'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'20159,067,932'Pyrazolopyridine kinase inhibitors'20159,029,546'Pyrazolopyridine kinase inhibitors'20158,987,454'Azaindoles useful as inhibitors of JAK and other protein kinases'20158,815,866'Aminopyridine kinase inhibitors'20148,741,931'Kinase inhibitors'20148,722,889'Azaindoles useful as inhibitors of JAK and other protein kinases'20148,637,511'Aminopyrimidines useful as kinase inhibitors'20148,569,337'Tri-cyclic pyrazolopyridine kinase inhibitors'20138,563,576'Tri-cyclic pyrazolopyridine kinase inhibitors'20138,501,446'Azaindoles useful as inhibitors of JAK and other protein kinases'20138,377,926'Aminopyridine kinase inhibitors'20138,367,697'Kinase inhibitors'20138,188,281'Azaindoles useful as inhibitors of JAK and other protein kinases'20128,188,071'Amino substituted pyridines as potent kinase inhibitors'20128,173,635'Kinase inhibitors'20127,767,672'Aminopyrimidines useful as kinase inhibitors'20107,507,826'Azaindoles useful as inhibitors of JAK and other protein kinases'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2021Patents assigned to VERTEX PHARMA (26)· patent assignee history
2009–2015Based in Abingdon, GB· patent location history
2010Based in Oxon, GB· patent location history
2012–2015Patents assigned to BOYALL DEAN (12)· patent assignee history
2012–2015Patents assigned to FRAYSSE DAMIEN (10)· patent assignee history
2012–2015Patents assigned to JIMENEZ JUAN-MIGUEL (9)· patent assignee history
2012–2015Patents assigned to SETTIMO LUCA (9)· patent assignee history
2012–2021Based in Faringdon, GB· patent location history
2020Based in Farington, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA262009–2021
BOYALL DEANself122012–2015
FRAYSSE DAMIEN102012–2015
JIMENEZ JUAN-MIGUEL92012–2015
SETTIMO LUCA92012–2015
Locations
LocationPatentsSpan
Faringdon, GB142012–2021
Abingdon, GB112009–2015
Farington, GB12020
Oxon, GB12010